# Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

> **NCT05502458** · PHASE2 · COMPLETED · sponsor: **Zhejiang Cancer Hospital** · enrollment: 60 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Desflurane Adverse Reaction
- Propofol Adverse Reaction
- Circulating Tumor Cells

## Interventions

- **DRUG:** Desflurane
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT05502458
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2022-08-08
- **Final completion:** 2022-08-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05502458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05502458, "Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05502458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*